- Home
- PSNL vs DIAX Comparison
PSNL vs DIAX Comparison
Compare PSNL & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- DIAX
- Stock Information
- Founded
- PSNL 2011
- DIAX 2005
- Country
- PSNL United States
- DIAX United States
- Employees
- PSNL N/A
- DIAX N/A
- Industry
- PSNL Medical Specialities
- DIAX Finance Companies
- Sector
- PSNL Health Care
- DIAX Finance
- Exchange
- PSNL Nasdaq
- DIAX Nasdaq
- Market Cap
- PSNL 562.6M
- DIAX 523.0M
- IPO Year
- PSNL 2019
- DIAX N/A
- Fundamental
- Price
- PSNL $6.45
- DIAX $14.33
- Analyst Decision
- PSNL Strong Buy
- DIAX
- Analyst Count
- PSNL 5
- DIAX 0
- Target Price
- PSNL $8.00
- DIAX N/A
- AVG Volume (30 Days)
- PSNL 1.7M
- DIAX 96.6K
- Earning Date
- PSNL 08-06-2025
- DIAX 01-01-0001
- Dividend Yield
- PSNL N/A
- DIAX 7.93%
- EPS Growth
- PSNL N/A
- DIAX N/A
- EPS
- PSNL N/A
- DIAX N/A
- Revenue
- PSNL $85,694,000.00
- DIAX N/A
- Revenue This Year
- PSNL $0.45
- DIAX N/A
- Revenue Next Year
- PSNL $25.75
- DIAX N/A
- P/E Ratio
- PSNL N/A
- DIAX N/A
- Revenue Growth
- PSNL 15.57
- DIAX N/A
- 52 Week Low
- PSNL $2.61
- DIAX $12.80
- 52 Week High
- PSNL $7.79
- DIAX $15.12
- Technical
- Relative Strength Index (RSI)
- PSNL 48.39
- DIAX 54.01
- Support Level
- PSNL $6.12
- DIAX $14.17
- Resistance Level
- PSNL $6.67
- DIAX $14.38
- Average True Range (ATR)
- PSNL 0.48
- DIAX 0.11
- MACD
- PSNL -0.14
- DIAX -0.01
- Stochastic Oscillator
- PSNL 5.33
- DIAX 32.50
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.